MR-2-93-3 , CAS No.2941228-90-4

CAS: 2941228-90-4 Cat. No.: M1439938 Formula: C89H150N2O8 Peso molecolare: 1376.15
Disponibile su ordine
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
5mg
M1439938-5mg
Su ordinazione · 8–12 settimane
548,32€
Enter a quantity for the sizes you want to add.

Panoramica

MR-2-93-3 is a long-chain fatty acid that can be used to deliver polynucleotides.

Specifiche

Condizioni di conservazione di stoccaggio
Store at -20°C
Spedito in
Ice chest + Ice pads
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Nomi e identificatori
Peso molecolare
1376.15

Dati avanzati

Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

No tested application protocols are provided in the Product Data for MR-2-93-3. Refer to your internal assay SOPs and validate concentration ranges, solvent tolerances, and incubation conditions empirically.

Common research practices for small-molecule screening compounds (general guidance, not product-specific)

  • Stock preparation: Dissolve in anhydrous DMSO to 10–50 mM; vortex and sonicate briefly if needed. Filter if particulate persists and the compound is stable.
  • Working solutions: Dilute stocks into assay buffer immediately before use to minimize precipitation; keep final DMSO ≤0.1–1% (biochemical) or ≤0.5–2% (cellular), as assay permits.
  • Plate handling: Use low-bind plastics; pre-equilibrate plates to assay temperature; minimize edge effects and solvent evaporation.
  • Storage of aliquots: Store single-use aliquots at −20°C to avoid freeze–thaw cycles; protect from light if the compound is chromophoric (unknown for this item).

For authoritative, product-specific protocols, consult the CoA/Spec Sheet or contact Aladdin Scientific.

Biological Roles
  • No biological role, target, or pathway annotation is provided for MR-2-93-3 in the Product Data.
  • As a screening library member, it may be evaluated empirically across biochemical or cellular assays to discover activity; any observed effects should be considered preliminary until target engagement is confirmed via orthogonal methods (e.g., biophysics, genetics, chemoproteomics).
  • Without structural information, predictions about ADME, permeability, and promiscuity (e.g., PAINS risk) cannot be made. Upon disclosure, consider in silico triage (substructure filters, cLogP, TPSA) and confirmatory counterscreens to exclude assay interference mechanisms (aggregation, redox cycling, fluorescence/quenching, detergent sensitivity).
  • All uses are for research purposes only; no clinical, diagnostic, or therapeutic applications are supported.
Buffer Applications

This product is a discrete small molecule rather than a buffering agent. No buffer-related properties (pKa values, buffering ranges) are provided.

  • If preparing assay solutions, use standard biological buffers (e.g., PBS, HEPES, Tris) that are compatible with the assay and the compound’s solubility/stability profile. Maintain organic co-solvent content (e.g., DMSO) at the minimum effective level (commonly ≤0.1–1% v/v in biochemical assays; up to 0.5–2% v/v in some cell-based assays, subject to tolerance testing).
  • Avoid assigning buffering function to MR-2-93-3; use purpose-built buffer systems.
Green Alternatives

Green chemistry considerations depend on the compound’s structure, hazard profile, and solvent system. Because structure and hazards are not provided for MR-2-93-3, specific alternatives cannot be prescribed.

General guidance for greener practice with small-molecule screening compounds

  • Prefer greener dissolution media when feasible:
    • Start with water or buffer containing minimal DMSO (≤1–2%) if the compound is sufficiently soluble and stable.
    • If an organic solvent is required, consider ethanol or isopropanol before higher-impact amide solvents; validate assay compatibility.
  • Minimize solvent volumes and use microplate-based dilution schemes to reduce waste.
  • Employ microscale reactions and high-throughput purification (e.g., mass-directed prep) to limit solvent consumption if synthetic elaboration is pursued post-hit.
  • Ensure proper waste segregation and explore solvent recycling where permitted.

Tradeoffs

  • Greener solvents may provide lower solubility or reduced chemical stability for certain scaffolds; balance environmental impact against data quality and compound integrity on a case-by-case basis.
Pharmaceutical Uses
  • No excipient role, pharmacopeial status, or formulation use is provided for MR-2-93-3. It is supplied strictly for research use only.
  • In medicinal chemistry research (non-clinical), screening compounds can be formulated short-term for in vitro assay compatibility (e.g., DMSO stocks) or exploratory in vivo studies after full characterization and institutional approval. This product listing does not provide such suitability; users must generate their own data package if considering non-clinical studies.
  • Do not use in human or veterinary applications. No GMP status is implied or claimed.
Physical Properties

Item-specific physicochemical data are not supplied in the Product Data. Do not treat the following as specifications; consult the CoA/Spec Sheet for authoritative values.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point (literature/expected for many library solids): varies widely; not defined for this item.
  • Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD, pKa, refractive index: Not specified for this item; refer to CoA/Spec Sheet.

General guidance (literature/good practice for screening compounds)

  • Initial dissolution: DMSO is commonly used to prepare 10–50 mM stocks for small-molecule libraries; verify solubility empirically.
  • Secondary solvents: If DMSO solubility is limited, co-solvents such as DMF, ethanol, or aqueous buffers with co-solvent (≤1–2% v/v DMSO) may be evaluated after confirming compound compatibility and assay tolerance.
  • Light/moisture/air sensitivity: Not specified for this item; handle under ambient conditions unless otherwise stated on the CoA. When in doubt, minimize exposure to light and moisture.
Quality and Grades
  • Grade/purity: Not specified for this item; refer to CoA/Spec Sheet.

Interpretation and guidance

  • In the absence of a declared grade (e.g., screening-grade, ≥95% HPLC, or analytical standard), users should consult the lot-specific CoA for:
    • Assay/purity method (HPLC/UPLC, GC, qNMR) and result
    • Identity confirmation (MS, NMR, HRMS)
    • Residual solvent profile and water content (if measured)
    • Any stabilizers or counter-ions present
  • For HTS/fragment/lead discovery work, typical acceptance criteria are ≥90–95% purity by an orthogonal analytical method with confirmed identity. Verify that the supplied lot meets your internal thresholds.
  • UV behavior for analytical methods (e.g., HPLC-UV cutoff) and impurity profile are not provided; if low-UV applications are planned, request UV spectra or use MS/ELSD detection.
  • If you require a defined salt form, isotope labeling, or impurity controls, contact Aladdin Scientific for custom sourcing or requalification.
Reaction and Applications

This product is listed as a small-molecule library member intended primarily for research screening and chemical biology. No structure or functional group information is provided, so synthetic reactivity or named-reaction applicability cannot be assigned.

  • Intended uses (research-only, non-clinical):
    • Assay development, primary/secondary screening, mechanism-of-action studies after target deconvolution.
    • Profiling in phenotypic assays or chemoproteomic workflows, contingent upon availability of the structure for probe design.
  • If used in medicinal chemistry follow-up, obtain full structural disclosure and analytical data to enable:
    • Solubility and stability assessment across pH 2–9 and under redox/light stress.
    • Metabolic soft spot analysis (microsomes/S9) and permeability when target-relevant.
  • Without item-specific functionality, do not assume compatibility with coupling, protection/deprotection, or late-stage derivatization.

Note: For any chemical transformations or conjugations involving MR-2-93-3, consult the CoA/structure and perform small-scale feasibility studies with appropriate controls.

Reaction Conditions

No structure or functional group information is provided for MR-2-93-3; therefore, specific reaction conditions, catalysts, or transformation guidelines cannot be recommended.

General considerations if chemical modification is contemplated after structure disclosure

  • Solvent: Choose based on solubility and stability (e.g., anhydrous DCM, MeCN, THF, dioxane, DMF) following standard medicinal chemistry practice.
  • Temperature: Begin at ambient temperature and escalate cautiously; many heterocycles or sensitive motifs may degrade under strong acid/base or prolonged heating.
  • Catalysts/bases: Select according to functional handles (e.g., Pd for cross-couplings, HATU/EDC for amide formation) only after verifying compatibility.
  • Controls: Include no-compound and vehicle controls to detect assay artifacts introduced by residual reagents or byproducts.

These notes are general literature guidance and are not specifications for MR-2-93-3.

Safety and Handling
  • GHS classification, pictograms, hazard statements: Not specified for this item; refer to SDS for MR-2-93-3 (SKU M1439938).
  • Signal word: Not specified; refer to SDS.

General laboratory precautions (good practice)

  • PPE: Wear lab coat, safety glasses or goggles, and suitable gloves (e.g., nitrile). Use in a fume hood to avoid inhalation of dust or vapors.
  • Avoid ingestion, inhalation, and skin/eye contact. Wash thoroughly after handling.
  • Storage incompatibilities: Unknown for this item; segregate from strong oxidizers, strong acids/bases, and reducing agents until specific compatibility is known from SDS.
  • First aid (overview; defer to SDS):
    • Inhalation: Move to fresh air; seek medical advice if symptoms persist.
    • Skin/eye contact: Rinse with water for at least 15 minutes; remove contaminated clothing; obtain medical attention if irritation persists.
    • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.
  • Spill/leak response: Avoid dust formation; absorb liquids with inert material; collect solids using HEPA-filtered vacuum or damp methods; dispose per institutional and regulatory requirements.
  • Fire safety: Specific flammability not provided. Use CO2, dry chemical, or foam as appropriate. Firefighters should wear self-contained breathing apparatus.
  • Peroxide formation/instability: No item-specific risk stated; assess based on actual structure once disclosed in the CoA.

Always consult the official SDS for authoritative hazard and response information.

Solvent Selection

Item-specific solubility and polarity are not provided. The following are general, literature-based practices for small-molecule screening compounds and should be validated experimentally for MR-2-93-3.

  • Primary stock solvent: DMSO is commonly used to prepare 10–50 mM stocks. Start with small-scale tests (e.g., 1–2 mg) to confirm dissolution without heating.
  • Co-solvent strategies:
    • If DMSO is insufficient, trial DMF or NMP (anhydrous) for initial dissolution, then back-dilute into assay buffer with ≤1–2% organic content.
    • For aqueous work, consider adding non-ionic surfactants (e.g., 0.01–0.05% Tween-20) if compatible with the assay to mitigate precipitation.
  • Volatile, low-toxicity options for workup/purification: Acetonitrile, ethanol, isopropanol, ethyl acetate can be evaluated once the compound’s stability is known.
  • Avoid:
    • Strongly basic or strongly acidic media unless stability is confirmed.
    • Prolonged heating during dissolution, which can promote degradation for sensitive chemotypes.

Comparison (general guidance)

  • DMSO vs ethanol: DMSO typically offers broader solubilization; ethanol may improve compatibility in select biochemical assays but supports lower top concentrations.
  • DMF/NMP: Greater solubilization power but higher boiling points and potential assay interference; restrict to minimal volumes.
Storage and Reconstitution
  • Storage conditions (from Product Data): Store at −20°C.
  • Shipping: Shipped in an ice chest with ice pads to maintain a cold chain during transit.
  • Container: Keep tightly closed in the original container. Purge with inert gas upon first opening if the CoA/SDS indicates air/moisture sensitivity (not specified for this item).
  • Reconstitution: Not specified for this item; refer to CoA/Spec Sheet. General practice for small molecules is to prepare DMSO stocks (e.g., 10–50 mM) after confirming solubility and stability.
  • Aliquoting: Prepare single-use aliquots to minimize freeze–thaw and adsorption losses. Label with concentration, solvent, and date.
  • Stability: No stability data (solid or in solution) are provided. As general guidance, store solutions at −20°C or below and use within a few weeks unless stability-indicating assays confirm longer-term integrity.
  • Light/moisture sensitivity: Not specified for this item; protect from light and humidity as a precaution until specific guidance is available.

Always defer to the lot-specific CoA and SDS for definitive storage, handling, and reconstitution instructions.

Structure and Identity
  • Product name: MR-2-93-3 (SKU: M1439938)
  • CAS: 2941228-90-4
  • Category: Small molecule / compound library member (research screening compound)
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.

Structural description

  • Item-specific structural features (ring systems, heteroatoms, stereochemistry) are not provided in the Product Data. Please consult the CoA/SDS or structure disclosure associated with the specific lot for exact structural details.
  • As a library member designated “MR-2-93-3,” it is intended for use as a discrete chemical entity in screening and chemical biology; no biological target or scaffold class is assigned in the provided data.
Synthetic Utility
  • The Product Data do not disclose functional groups or reactivity. As such, MR-2-93-3 should not be presumed to serve as a synthetic intermediate or building block.
  • If synthetic elaboration is desired (e.g., SAR expansion, probe conjugation), obtain the full structure, assess functional handles, and confirm stability and purity. Typical next steps may include:
    • Determining presence of derivatizable moieties (amines, acids, halides, alcohols) for amide coupling, Suzuki/SONOGASHIRA/Negishi couplings, or alkylation/acylation—only after structure is known.
    • Establishing robustness to common reaction conditions (base/acid, temperature, metal catalysts) via small-scale scouting.
  • Until structure and analytical data are available, treat MR-2-93-3 as a finished research article rather than a reagent for synthesis.
Target Specificity

Not applicable. MR-2-93-3 is listed as a small-molecule library member with no target, epitope, or biological specificity data provided in the Product Data. No antigen, clone, isotype, or species reactivity applies.

Domande frequenti

How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 2941228-90-4, the molecular formula is C89H150N2O8, and the molecular weight is 1376.15 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.